Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew F Shorr

Showing results (201-210 of 322) with videos related to

Pageof 33
Sort By:
Chest|April 30, 2011
Validation of a novel risk score for severity of illness in acute exacerbations of COPDAndrew F Shorr, Xiaowu Sun, Richard S Johannes, et al.
Antibiotics (Basel, Switzerland)|March 28, 2025
Unfavorable Outcomes and Their Risk Factors in Hospitalized Patients with <i>Staphylococcus aureus</i> Bacteremia in the US: A Multicenter Retrospective Cohort Study, 2020-2022Marya D Zilberberg, Brian H Nathanson, Rolf Wagenaar, et al.
Respiratory Medicine|January 24, 2021
Pneumococal community-acquired pneumonia in the intensive care unit: Azithromycin remains protective despite macrolide resistanceAndrew F Shorr, James Simmons, Nicolas Hampton, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 28, 2015
A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real worldYin Wan, Shawn X Sun, Shelby Corman, et al.
Antibiotics (Basel, Switzerland)|January 25, 2025
Comparative Outcomes of Meropenem-Vaborbactam vs. Ceftazidime-Avibactam Among Adults Hospitalized with an Infectious Syndrome in the US, 2019-2021Marya D Zilberberg, Brian H Nathanson, Mark A Redell, et al.
Critical Care Medicine|January 13, 2021
Nosocomial InfectionMarin H Kollef, Antoni Torres, Andrew F Shorr, et al.
Chest|March 16, 2006
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosisChristopher J Lettieri, Steven D Nathan, Scott D Barnett, et al.
Annals of Internal Medicine|October 8, 2019
Ensuring Sustainability of Needed Antibiotics: Aiming for the DART BoardBrad Spellberg, Travis B Nielsen, David N Gilbert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2011
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance SummitMarin H Kollef, Yoav Golan, Scott T Micek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2018
Epidemiology and Outcomes of Hospitalizations With Invasive Aspergillosis in the United States, 2009-2013Marya D Zilberberg, Brian H Nathanson, Rachel Harrington, et al.
Pageof 33

Showing results (201-210 of 322) with videos related to

Sort By:
Pageof 33
Chest|April 30, 2011
Validation of a novel risk score for severity of illness in acute exacerbations of COPDAndrew F Shorr, Xiaowu Sun, Richard S Johannes, et al.
Antibiotics (Basel, Switzerland)|March 28, 2025
Unfavorable Outcomes and Their Risk Factors in Hospitalized Patients with <i>Staphylococcus aureus</i> Bacteremia in the US: A Multicenter Retrospective Cohort Study, 2020-2022Marya D Zilberberg, Brian H Nathanson, Rolf Wagenaar, et al.
Respiratory Medicine|January 24, 2021
Pneumococal community-acquired pneumonia in the intensive care unit: Azithromycin remains protective despite macrolide resistanceAndrew F Shorr, James Simmons, Nicolas Hampton, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 28, 2015
A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real worldYin Wan, Shawn X Sun, Shelby Corman, et al.
Antibiotics (Basel, Switzerland)|January 25, 2025
Comparative Outcomes of Meropenem-Vaborbactam vs. Ceftazidime-Avibactam Among Adults Hospitalized with an Infectious Syndrome in the US, 2019-2021Marya D Zilberberg, Brian H Nathanson, Mark A Redell, et al.
Critical Care Medicine|January 13, 2021
Nosocomial InfectionMarin H Kollef, Antoni Torres, Andrew F Shorr, et al.
Chest|March 16, 2006
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosisChristopher J Lettieri, Steven D Nathan, Scott D Barnett, et al.
Annals of Internal Medicine|October 8, 2019
Ensuring Sustainability of Needed Antibiotics: Aiming for the DART BoardBrad Spellberg, Travis B Nielsen, David N Gilbert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2011
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance SummitMarin H Kollef, Yoav Golan, Scott T Micek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2018
Epidemiology and Outcomes of Hospitalizations With Invasive Aspergillosis in the United States, 2009-2013Marya D Zilberberg, Brian H Nathanson, Rachel Harrington, et al.
Pageof 33